Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older (there is no upper age limit)
- People whose general health and ability to carry out daily activities meets a certain minimum level, based on standard medical scoring scales (confirm with trial site)
- People who have been diagnosed with a type of cancer called adenocarcinoma, located in the stomach or where the stomach meets the oesophagus, confirmed by laboratory testing of cells or tissue
- People whose kidneys and blood cell counts are within acceptable ranges, including white blood cell count, infection-fighting cells (neutrophils), platelets, and a measure of kidney function (confirm with trial site for specific values)
- People whose cancer has spread to the lining of the abdomen (the peritoneum), confirmed either by fluid testing or by a surgical examination procedure
- People who have already completed a course of chemotherapy given before surgery (certain other treatments such as HER2-targeted therapy or immunotherapy may have continued alongside this)
- Both English-speaking and non-English-speaking people are eligible
Who may not be able to join:
- People whose cancer has spread beyond the abdominal lining to other organs, such as the liver, brain, or lungs
- People who have an active infection, such as pneumonia or a wound infection, that would interfere with treatment
- Women who are pregnant (a pregnancy test will be required); women who could become pregnant must agree to use reliable contraception and not breastfeed; men who could father a child must agree to use appropriate contraception or abstinence
- People with unstable chest pain (angina) or moderate-to-severe heart failure
- People who, for reasons such as cognitive difficulties, may not be able to follow the study procedures and appointments
- People who have previously had a severe or life-threatening allergic reaction to the chemotherapy used in this study
- People who have had previous surgery that would make it unsafe to perform the surgical procedures involved in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brian Badgwell, MD, M.D. Anderson Cancer Center
Phone: 713-535-0703
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.